Stockreport

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF Announced positive initial data from first three subjects with type 1 diabetes treated with tegoprubart as part of immunosuppression regimen following islet transplanta [Read more]